Clinical Relevance of the Interaction When Switching Non-Nucleoside Reverse Transcriptase Inhibitors in Patients Infected with HIV

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|9|4|399-403

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.9, Iss.4, 2014-11, pp. : 399-403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Treating HIV-Infected Children

By Penazzato Martina Giaquinto Carlo

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2131-2149

Adis International

Access to resources Recommend Favorite

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M. Morrison I.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors

By Smith P.F.

Clinical Pharmacokinetics, Vol. 40, Iss. 12, 2001-01 ,pp. : 893-905

Adis International

Access to resources Recommend Favorite

The Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Children with HIV-1 Infection

By Maddocks S. Dwyer D.

Pediatric Drugs, Vol. 3, Iss. 9, 2001-01 ,pp. : 681-702

Adis International

Access to resources Recommend Favorite